RT Journal Article
T1 Nanoparticles for Multimodal Antivascular Therapeutics: Dual Drug Release, Photothermal and Photodynamic Therapy.
A1 Paris, J.L.
A1 Villaverde, Gonzalo
A1 Gómez-Graña, Sergio
A1 Vallet Regí, María Dulce Nombre
AB The poor delivery of nanoparticles to target cancer cells hinders their success in the clinical setting. In this work, an alternative target readily available for circulating nanoparticles has been selected to eliminate the need for nanoparticle penetration in the tissue: the tumor blood vessels. A tumor endothelium-targeted nanoparticle (employing an RGD-containing peptide) capable of co-delivering two anti-vascular drugs (one anti-angiogenic drug and one vascular disruption agent) is here presented. Furthermore, the nanodevice presents two additional anti-vascular capabilities upon activation by Near-Infrared light: provoking local hyperthermia (by gold nanorods in the system) and generating toxic reactive oxygen species (by the presence of a photosensitizer). RGD-targeting is shown to increase uptake by HUVEC cells, and while the nanoparticles are shown not to be toxic for these cells, upon Near-Infrared irradiation their almost complete killing is achieved. The combination of all four therapeutic modalities is then evaluated in an ex ovo fibrosarcoma xenograft model, which shows a significant reduction in the number of blood vessels irrigating the xenografts when the nanoparticles are present, as well as the destruction of the existing blood vessels upon irradiation. These results suggest that the combination of different anti-vascular therapeutic strategies in a single nanocarrier appears promising and should be further explored in the future.
PB Elsevier
SN 1742-7061
YR 2019
FD 2019-11-06
LK https://hdl.handle.net/20.500.14352/5968
UL https://hdl.handle.net/20.500.14352/5968
LA eng
NO RESEARCHER ID D-9318-2017 (Juan Luis Paris de la Fuente)ORCID 0000-0001-8950-283X (Juan Luis Paris de la Fuente)RESEARCHER ID L-2250-2014 (Gonzalo Villaverde Cantizano)ORCID 0000-0003-2065-0417 (Gonzalo Villaverde Cantizano)RESEARCHER ID G-7562-2016 (Sergio Gómez Graña)ORCID 0000-0002-7736-051X (Sergio Gómez Graña)RESEARCHER ID M-3378-2014 (María Vallet Regí)ORCID 0000-0002-6104-4889 (María Vallet Regí)
NO Unión Europea. H2020
DS Docta Complutense
RD 2 may 2024